Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dextromethorphan is a cough suppressant used in many cough and cold medicines. In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Dextromethorphan. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug cyp2d6 effects dissociative use major receptor dextrorphan serotonin combination approved metabolite doses cough nmda used medications including also number
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dextromethorphan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dextromethorphan | Addiction liability | Low–moderate | 1.00 | infobox |
| Dextromethorphan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dextromethorphan | ATC code | R05DA09 (WHO) | 1.00 | infobox |
| Dextromethorphan | Bioavailability | 11% | 1.00 | infobox |
| Dextromethorphan | CAS Number | 125-71-3 Y | 1.00 | infobox |
| Dextromethorphan | ChEBI | CHEBI:4470 N | 1.00 | infobox |
| Dextromethorphan | ChEMBL | ChEMBL52440 Y | 1.00 | infobox |
| Dextromethorphan | ChemSpider | 13109865 Y | 1.00 | infobox |
| Dextromethorphan | Chirality | Dextrorotatory enantiomer | 1.00 | infobox |
| Dextromethorphan | CompTox Dashboard (EPA) | DTXSID3022908 | 1.00 | infobox |
| Dextromethorphan | Drug class | Antitussive; Serotonin–norepinephrine reuptake inhibitor; NMDA receptor antagonist; Dissociative hallucinogen | 1.00 | infobox |
| Dextromethorphan | DrugBank | DB00514 Y | 1.00 | infobox |
| Dextromethorphan | Duration of action | 3–8 hours | 1.00 | infobox |
| Dextromethorphan | ECHA InfoCard | 100.004.321 | 1.00 | infobox |
| Dextromethorphan | Elimination half-life | 2–4 hours (extensive metabolizers); 24 hours (poor metabolizers) | 1.00 | infobox |
| Dextromethorphan | Excretion | Kidney | 1.00 | infobox |
| Dextromethorphan | Formula | C18H25NO | 1.00 | infobox |
| Dextromethorphan | IUPHAR/BPS | 6953 | 1.00 | infobox |
| Dextromethorphan | KEGG | D03742 Y | 1.00 | infobox |
| Dextromethorphan | Legal status | AU: S2 (Pharmacy medicine) | 1.00 | infobox |
| Dextromethorphan | Legal status | CA: OTC | 1.00 | infobox |
| Dextromethorphan | Legal status | UK: P (Pharmacy medicines) | 1.00 | infobox |
| Dextromethorphan | Legal status | US: OTC | 1.00 | infobox |
| Dextromethorphan | Legal status | UN: Unscheduled | 1.00 | infobox |
| Dextromethorphan | Legal status | SE: Förteckning V | 1.00 | infobox |
| Dextromethorphan | License data | US DailyMed: Dextromethorphan | 1.00 | infobox |
| Dextromethorphan | MedlinePlus | a682492 | 1.00 | infobox |
| Dextromethorphan | Melting point | 111 °C (232 °F) | 1.00 | infobox |
| Dextromethorphan | Metabolism | Liver enzymes: major CYP2D6, minor CYP3A4, and minor CYP3A5 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.